Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 16/20 | 0.49 |
| ▸ | CA1 | P00915 | 12/20 | 0.46 |
| ▸ | CA9 | Q16790 | 11/20 | 0.46 |
| ▸ | CA7 | P43166 | 10/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 10/20 | 0.46 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | CPS1 | P31327 | 1/20 | 0.38 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23628462 | 0.88 | CA2 (0.58) | CA2CA1CA9CA7CA14 | |
| SCHEMBL20502378 | 0.85 | CA2 (0.59) | CA2CA1CA9CA7CA14 | |
| Hydrochloric Acid SCHEMBL22205236 | 0.85 | CA2 (0.47) | CA2CA1CA9CA7CA14 | |
| SCHEMBL23628480 | 0.79 | CA2 (0.57) | CA2CA1CA9CA7CA14 | |
| Hydrochloric Acid SCHEMBL22205231 | 0.78 | CA2 (0.56) | CA2CA1CA9CA7CA14 | |
| Hydrochloric Acid SCHEMBL18668453 | 0.78 | CA2 (0.56) | CA2CA1CA9CA7CA14 | |
| SCHEMBL18687990 | 0.76 | CA2 (0.68) | CA2CA1CA9CA7CA12 | |
| SCHEMBL20421458 | 0.76 | CA2 (0.39) | CA2CA1CA9CA7CA14 | |
| SCHEMBL28723643 | 0.74 | CA2 (0.52) | CA2CA1CA9CA7CA14 | |
| SCHEMBL29571991 | 0.74 | CA2 (0.50) | CA2CA1CA9CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922415-B | Novel bicyclic compounds as dual ATX/CA inhibitors | 豪夫迈·罗氏有限公司 | 2022-04-15 | — | — | CN | claimed |
| EP-3353178-B1 | BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS | HOFFMANN LA ROCHE (CH) | 2021-07-14 | — | — | EP | claimed |
| CN-107922415-B | Novel bicyclic compounds as dual ATX/CA inhibitors | 豪夫迈·罗氏有限公司 | 2022-04-15 | — | — | CN | disclosed |